Patents by Inventor Ravindra Tejwani

Ravindra Tejwani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of pimavanserin
    Patent number: 11452721
    Abstract: Provided herein are capsules containing pimavanserin, processes for manufacturing said capsule, and pharmaceutical compositions containing pimavanserin.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: September 27, 2022
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Ravindra Tejwani, Stephen Edward Abele, Emanuel Joseph Vizzotti
  • FORMULATIONS OF PIMAVANSERIN
    Publication number: 20220193057
    Abstract: Provided herein are capsules containing pimavanserin, processes for manufacturing said capsule, and pharmaceutical compositions containing pimavanserin.
    Type: Application
    Filed: March 14, 2022
    Publication date: June 23, 2022
    Inventors: Ravindra Tejwani, Stephen Edward Abele, Emanuel Joseph Vizzotti
  • FORMULATIONS OF PIMAVANSERIN
    Publication number: 20210283118
    Abstract: Provided herein are capsules containing pimavanserin, processes for manufacturing said capsule, and pharmaceutical compositions containing pimavanserin.
    Type: Application
    Filed: October 26, 2020
    Publication date: September 16, 2021
    Inventors: Ravindra Tejwani, Stephen edward Abele, Emanuel Joseph Vizzotti
  • Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di-amino acid salts, and mono- and di-amino acid ester salts
    Publication number: 20070270617
    Abstract: Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4.
    Type: Application
    Filed: March 1, 2006
    Publication date: November 22, 2007
    Inventors: John Venit, Mandar Dali, Manisha Dali, Yande Huang, Charles Dahlheim, Ravindra Tejwani
  • Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts and mono-and di-amino acid ester salts
    Publication number: 20060172980
    Abstract: Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4.
    Type: Application
    Filed: March 1, 2006
    Publication date: August 3, 2006
    Inventors: John Venit, Mandar Dali, Manisha Dali, Yande Huang, Charles Dahlheim, Ravindra Tejwani
  • Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
    Publication number: 20060165772
    Abstract: Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4.
    Type: Application
    Filed: March 1, 2006
    Publication date: July 27, 2006
    Inventors: John Venit, Mandar Dali, Manisha Dali, Yande Huang, Charles Dahlheim, Ravindra Tejwani
  • Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
    Publication number: 20060166942
    Abstract: Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4.
    Type: Application
    Filed: March 1, 2006
    Publication date: July 27, 2006
    Inventors: John Venit, Mandar Dali, Manisha Dali, Yande Huang, Charles Dahlheim, Ravindra Tejwani
  • Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
    Publication number: 20050153939
    Abstract: Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4.
    Type: Application
    Filed: February 11, 2005
    Publication date: July 14, 2005
    Applicant: Bristol-Myers Squibb Company
    Inventors: John Venit, Mandar Dali, Manisha Dali, Yande Huang, Charles Dahlheim, Ravindra Tejwani